KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Short-term Investments (2018 - 2020)

Elanco Animal Health's Short-term Investments history spans 3 years, with the latest figure at $11.0 million for Q4 2020.

  • On a quarterly basis, Short-term Investments changed 0.0% to $11.0 million in Q4 2020 year-over-year; TTM through Dec 2020 was $11.0 million, a 0.0% change, with the full-year FY2020 number at $11.0 million, changed 0.0% from a year prior.
  • Short-term Investments hit $11.0 million in Q4 2020 for Elanco Animal Health, roughly flat from $11.0 million in the prior quarter.
  • Over the last five years, Short-term Investments for ELAN hit a ceiling of $634.9 million in Q3 2018 and a floor of $11.0 million in Q4 2019.
  • Historically, Short-term Investments has averaged $94.4 million across 3 years, with a median of $11.0 million in 2019.
  • Biggest five-year swings in Short-term Investments: tumbled 98.25% in 2019 and later changed 0.0% in 2020.
  • Tracing ELAN's Short-term Investments over 3 years: stood at $202.7 million in 2018, then tumbled by 94.57% to $11.0 million in 2019, then changed by 0.0% to $11.0 million in 2020.
  • Business Quant data shows Short-term Investments for ELAN at $11.0 million in Q4 2020, $11.0 million in Q3 2020, and $11.0 million in Q2 2020.